Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease - Concepedia

Concepedia

Publication | Open Access

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

DOI Full Paper Access

477

Citations

27

References

2009

Year

Konstantinos Κarmiris, Gilles Paintaud, Maja Noman, Charlotte Magdelaine–Beuzelin, Marc Ferrante, Danielle Degenne, Karolien Claes, Tamara Coopman, Nele Van Schuerbeek, Gert Van Assche,

Gastroenterology

InflammationChronic Inflammatory DiseasesRheumatoid DisorderAllergyAutoimmune DiseaseMedicineImmunologyAdalimumab TherapyLong-term OutcomeAutoimmunityInflammatory Rheumatic DiseaseUlcerative ColitisTrough Serum LevelsRheumatoid Arthritis

References

	Year	Citations

Page 1

Page 1